{
  "daily_take": "Test data: Breakthrough gene therapy shows promising results in early trials for rare childhood disease, while FDA faces pressure to streamline approval processes for life-saving treatments.",
  "weekly_top_story": {
    "headline": "Test Data: Revolutionary CAR-T Cell Therapy Shows 90% Remission Rate",
    "summary": "A new CAR-T cell therapy targeting pediatric leukemia has demonstrated remarkable efficacy in Phase II trials, with 90% of patients achieving complete remission after six months.",
    "source": "The Lancet",
    "importance": 5,
    "impact_to_me": 5,
    "category": "Research",
    "url": "https://www.thelancet.com/car-t-therapy"
  },
  "stories": [
    {
      "headline": "Test Data: FDA Announces New Fast-Track Program for Gene Therapies",
      "summary": "The FDA has unveiled a new expedited review pathway aimed at accelerating the approval of gene therapies for rare diseases, potentially cutting approval times by up to 50%.",
      "source": "STAT News",
      "importance": 5,
      "impact_to_me": 4,
      "category": "Policy",
      "url": "https://www.statnews.com/fda-fast-track"
    },
    {
      "headline": "Test Data: Telehealth Reimbursement Rules Expanded for Rural Areas",
      "summary": "CMS has expanded Medicare reimbursement for telehealth services in rural communities, removing geographic restrictions that previously limited access to virtual care.",
      "source": "Fierce Healthcare",
      "importance": 4,
      "impact_to_me": 3,
      "category": "Policy",
      "url": "https://www.fiercehealthcare.com/telehealth"
    },
    {
      "headline": "Test Data: AI Diagnostic Tool Achieves Radiologist-Level Accuracy",
      "summary": "A new artificial intelligence system for detecting lung cancer on CT scans has matched or exceeded the diagnostic accuracy of experienced radiologists in a large clinical trial.",
      "source": "NEJM",
      "importance": 4,
      "impact_to_me": 4,
      "category": "Tech",
      "url": "https://www.nejm.org/ai-diagnostic"
    }
  ],
  "other_news": [
    {
      "headline": "Test Data: Pharma Giants Merge in $50B Deal to Focus on Rare Diseases",
      "summary": "Two major pharmaceutical companies have announced a merger valued at $50 billion, creating a new entity that will focus exclusively on developing treatments for ultra-rare genetic disorders.",
      "source": "Fierce Pharma",
      "url": "https://www.fiercepharma.com/merger"
    },
    {
      "headline": "Test Data: New Study Links Gut Microbiome to Autoimmune Disease Progression",
      "summary": "Researchers have identified specific gut bacteria patterns associated with the progression of multiple sclerosis, opening new avenues for treatment approaches.",
      "source": "Nature Medicine",
      "url": "https://www.nature.com/microbiome-autoimmune"
    }
  ]
}